-
Satellos receives clearance by FDA to initiate Phase 2 study in Duchenne
Satellos Biosciences has received Investigational New Drug (IND) clearance from the FDA, as well as
-
In Case You Missed It…
Quest Media is an innovative, adaptive lifestyle platform from MDA. With the power of this
-
Finding the right words to describe our life experiences
Words matter. For that reason, I’d like to share my thoughts on language, chronic illness,
-
Dyne Therapeutics Announces Positive Topline Results from Phase 1/2 DELIVER Trial of Z-Rostudirsen in Duchenne
Dyne Therapeutics has announced positive topline results from its Registrational Expansion Cohort (REC) of the
-
Clinical Research Alert: Phase 1b Study of SRD-001 in Adults with DMD-Related Cardiomyopathy
Researchers at Sardocor Corp are seeking adults with cardiomyopathy (heart disease) secondary to Duchenne muscular dystrophy
-
Holiday Gift Wrapping Made Easier: Accessible Tips & Tricks
As the holidays approach, ‘tis the season for holiday hacks and tips. One key (and
-
Protected: Honoring Every Journey in Duchenne and Becker: Advancing Therapies, Access, and Care For All
This content is password protected. To view it please enter your password below: Password: The
-
Planning a ‘Krank’ Christmas and getaway with accessibility in mind
Navigating the holidays creates some logistical problems for my family. It’s not because there are nine
-
Progress Through Partnership: MDA’s Collaborative Research Grants Drive Neuromuscular Science Forward
Progress in neuromuscular research has always depended on collaboration — scientists, families, advocates, and organizations
-
DMD treatment Kymbee launches with support program for patients
Upsher-Smith Laboratories is launching a new corticosteroid treatment for people with Duchenne muscular dystrophy (DMD)
